Loading
Latest filing published 28 Mar 2022 for Marker Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Our data holds just one disclosure by Peter L. Hoang, dated 28 March 2022, reporting a share grant in Marker Therapeutics, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration